Biological Grafts for Hemodialysis Access: Historical Lessons, State-of-the-Art and Future Directions

Seminars in Dialysis

Volumn 26, Issue 2, 2013, Pages 233-239

  Dukkipati, Ramanath ^a   Peck, Marissa ^b   Dhamija, Rajiv ^c   Hentschel, Dirk M ^d   Reynolds, Tyler ^a   Tammewar, Gautam ^a   Mcallister, Todd ^b,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Cytograft Tissue Engineering Inc   (United States)

^c RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Saint Joseph's Translational Research Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF; POLYURETHAN; TISSUE SCAFFOLD;

ANIMAL; ANIMAL MODEL; ARTERIOVENOUS SHUNT; ARTICLE; GRAFT OCCLUSION; HUMAN; INDWELLING CATHETER; METHODOLOGY; RENAL REPLACEMENT THERAPY; TISSUE ENGINEERING; UNITED STATES; VASCULAR PATENCY; XENOGRAFT;

ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; GRAFT OCCLUSION, VASCULAR; HUMANS; MODELS, ANIMAL; POLYTETRAFLUOROETHYLENE; POLYURETHANES; RENAL DIALYSIS; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSPLANTATION, HETEROLOGOUS; UNITED STATES; VASCULAR PATENCY;

EID: 84875596518     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2012.01106.x     Document Type: Article

References (57)

1. NKF-DOQI clinical practice guidelines for vascular access: National kidney foundation-dialysis outcomes quality initiative. Am J Kidney Dis30:S150-S191, 1997
2. NKF-KDOQI: Clinical practice guidelines for vascular access. Am J Kidn Dis48:S176-S247, 2006
3. http://www.fistulafirst.org, 2011
4. Perera GB, Mueller MP, Kubaska SM, Wilson SE, Lawrence PF, Fujitani RM: Superiority of autogenous arteriovenous hemodialysis access: maintenance of function with fewer secondary interventions. Ann Vasc Surg18:66-73, 2004
5. Huber TS, Carter JW, Carter RL, Seeger JM: Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg38:1005-1011, 2003
6. Gibson KD, Gillen DL, Caps MT, Kohler TR, Sherrard DJ, Stehman-Breen CO: Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg34:694-700, 2001
7. Lynch JR, Mohan S, McClellan WM: Achieving the goal: results from the Fistula First Breakthrough Initiative. Curr Opin Nephrol Hypertens20:583-592, 2011
8. Lee T, Roy-Chaudhury P: Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis16:329-338, 2009
9. Beathard GA: Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int42:1390-1397, 1992
10. Haskal ZJ, Trerotola S, Dolmatch B, Schuman E, Altman S, Mietling S, Berman S, McLennan G, Trimmer C, Ross J, Vesely T: Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med362:494-503, 2010
11. Salman L, Asif A: Stent graft for nephrologists: concerns and consensus. Clin J Am Soc Nephrol5:1347-1352, 2010
12. Dahl SL, Kypson AP, Lawson JH, Blum JL, Strader JT, Li Y, Manson RJ, Tente WE, DiBernardo L, Hensley MT, Carter R, Williams TP, Prichard HL, Dey MS, Begelman KG, Niklason LE: Readily available tissue-engineered vascular grafts. Sci Transl Med3:68-69, 2011
13. Miller PE, Carlton D, Deierhoi MH, Redden DT, Allon M: Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis36:68-74, 2000
14. Schild AF, Perez E, Gillaspie E, Seaver C, Livingstone J, Thibonnier A: Arteriovenous fistulae vs. arteriovenous grafts: a retrospective review of 1, 700 consecutive vascular access cases. J Vasc Access9:231-235, 2008
15. Dasgupta MK: Biofilms and infection in dialysis patients. Semin Dial15:338-346, 2002
16. Kiyama H, Imazeki T, Kurihara S, Yoneshima H: Long-term follow-up of polyurethane vascular grafts for hemoaccess bridge fistulas. Ann Vasc Surg17:516-521, 2003
17. Vermeij CG, Smit FW, Elsman BH: Inability to monitor polyurethane haemodialysis vascular access graft by Doppler ultrasound. Nephrol Dial Transplant16:1089-1090, 2001
18. Klinkert P, Post PN, Breslau PJ, van Bockel JH: Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature. Eur J Vasc Endovasc Surg27:357-362, 2004
19. Meinhart JG, Deutsch M, Fischlein T, Howanietz N, Froschl A, Zilla P: Clinical autologous in vitro endothelialization of 153 infrainguinal ePTFE grafts. Ann Thorac Surg71:S327-S331, 2001
20. Zilla P, Fasol R, Deutsch M, Fischlein T, Minar E, Hammerle A, Krupicka O, Kadletz M: Endothelial cell seeding of polytetrafluoroethylene vascular grafts in humans: a preliminary report. J Vasc Surg6:535-541, 1987
21. Conte MS: The ideal small arterial substitute: a search for the Holy Grail?Faseb J12:43-45, 1998
22. Kakisis JD, Liapis CD, Breuer C, Sumpio BE: Artificial blood vessel: the Holy Grail of peripheral vascular surgery. J Vasc Surg41:349-354, 2005
23. Berardinelli L: Grafts and graft materials as vascular substitutes for haemodialysis access construction. Eur J Vasc Endovasc Surg32:203-211, 2006
24. Glickman MH, Lawson JH, Katzman HE, Schild AF, Fujitani RM: Challenges of hemodialysis access for high risk patients: Impact of mesenteric vein bioprosthetic graft. J Vasc Access4:73-80, 2003
25. Katzman HE, Glickman MH, Schild AF, Fujitani RM, Lawson JH: Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. J Am Coll Surg201:223-230, 2005
26. Kovalic AJ, Beattie DK, Davies AH: Outcome of ProCol, a bovine mesenteric vein graft, in infrainguinal reconstruction. Eur J Vasc Endovasc Surg24:533-534, 2002
27. Matsuura JH, Johansen KH, Rosenthal D, Clark MD, Clarke KA, Kirby LB: Cryopreserved femoral vein grafts for difficult hemodialysis access. Ann Vasc Surg14:50-55, 2000
28. Bolton WD, Cull DL, Taylor SM, Carsten CG III, Snyder BA, Sullivan TM, Youkey JR, Langan 3rd EM, Gray BH: The use of cryopreserved femoral vein grafts for hemodialysis access in patients at high risk for infection: a word of caution. J Vasc Surg36:464-468, 2002
29. Hutchin P, Jacobs JR, Devin JB, Shaughnessy S, Roland AS: Bovine graft arteriovenous fistulas for maintenance hemodialysis. Surg Gynecol Obstet141:255-258, 1975
30. Kaplan MS, Mirahmadi KS, Winer RL, Gorman JT, Dabirvaziri N, Rosen SM: Comparison of "PTFE" and bovine grafts for blood access in dialysis patients. Trans Am Soc Artif Intern Organs22:388-393, 1976
31. Kennealey PT, Elias N, Hertl M, Ko DS, Saidi RF, Markmann JF, Smoot EE, Schoenfeld DA, Kawai T: A prospective, randomized comparison of bovine carotid artery and expanded polytetrafluoroethylene for permanent hemodialysis vascular access. J Vasc Surg53:1640-1648, 2011
32. Ketharnathan V, Christie BA: Glutaraldehyde-tanned ovine collagen conduits as vascular xenografts in dogs: a preliminary report. Arch Surg115:967-969, 1980
33. Edwards GA, Roberts G: Development of an ovine collagen-based composite biosynthetic vascular prosthesis. Clin Mater9:211-223, 1992
34. Enzler MA, Rajmon T, Lachat M, Largiader F: Long-term function of vascular access for hemodialysis. Clin Transplant10:511-515, 1996
35. Palumbo R, Niscola P, Calabria S, Fierimonte S, Bevilacqua M, Scaramucci L, Tolu B, de Fabritiis P, Bondanini F: Long-term favorable results by arteriovenous graft with Omniflow II prosthesis for hemodialysis. Nephron Clin Pract113:c76-80, 2009
36. Shin'oka T, Imai Y, Ikada Y: Transplantation of a tissue-engineered pulmonary artery. N Engl J Med344:532-533, 2001
37. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H: Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg129:1330-1338, 2005
38. Gong Z, Niklason LE: Blood vessels engineered from human cells. Trends Cardiovasc Med16:153-156, 2006
39. Campbell JH, Efendy JL, Campbell GR: Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res85:1173-1178, 1999
40. Chue WL, Campbell GR, Caplice N, Muhammed A, Berry CL, Thomas AC, Bennett MB, Campbell JH: Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts. J Vasc Surg39:859-867, 2004
41. Sakai O, Kanda K, Ishibashi-Ueda H, Takamizawa K, Ametani A, Yaku H, Nakayama Y: Development of the wing-attached rod for acceleration of "Biotube" vascular grafts fabrication in vivo. J Biomed Mater Res B Appl Biomater83:240-247, 2007
42. L'Heureux N, Paquet S, Labbe R, Germain L, Auger FA: A completely biological tissue-engineered human blood vessel. Faseb J12:47-56, 1998
43. L'Heureux N, McAllister TN, de la Fuente LM: Tissue-engineered blood vessel for adult arterial revascularization. N Engl J Med357:1451-1453, 2007
44. McAllister TN, Maruszewski M, Garrido SA, Wystrychowski W, Dusserre N, Marini A, Zagalski K, Fiorillo A, Avila H, Manglano X, Antonelli J, Kocher A, Zembala M, Cierpka L, de la Fuente LM, L'Heureux N: Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet373:1440-1446, 2009
45. Davidson I, Hackerman C, Kapadia A, Minhajuddib A: Heparin bonded hemodialysis e-PTFE grafts result in 20% clot free survival benefit. J Vasc Access10:153-156, 2009
46. Paulson WD, Kishidze N, Kipiani K, Beridze N, DeVita MV, Shenoy S, Iyer SS: Safety and effficacy of local periadventitial delivery of sirolimus for improvinf hemodialysis AV graft patency. first human experience with sirolimu -eluting collagen membrane(Coll-R). Nephrol Dial Transplant27(3):1219-24, 2012
47. Lee BH, Nam HY, Kwon T, Kim SJ, Kwon GY, Jeon HJ, Lim HJ, Lee WK, Park JS, Ko JY, Kim DJ: Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis. Nephrol Dial Transplant21:2432-2438, 2006
48. Kelly B, Melhem M, Zhang J, Kasting G, Li J, Krishnamoorthy M, Heffelfinger S, Rudich S, Desai P, Roy-Chaudhury P: Perivascular paclitaxel wraps block arteriovenous graft stenosis in a pig model. Nephrol Dial Transplant21:2425-2431, 2006
49. Kohler TR, Toleikis PM, Gravett DM, Avelar RL: Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh. J Vasc Surg45:1029-1037; discussion 1037-1028, 2007
50. Ko PJ, Hsieh HC, Chu JJ, Lin PJ, Liu YH: Patency rates and complications of Exxcel yarn-wrapped polytetrafluoroethylene grafts versus Gore-tex stretch polytetrafluoroethylene grafts: a prospective study. Surg Today34:409-412, 2004
51. Hiltunen MO, Laitinen M, Turunen MP, Jeltsch M, Hartikainen J, Rissanen TT, Laukkanen J, Niemi M, Kossila M, Hakkinen TP, Kivela A, Enholm B, Mansukoski H, Turunen AM, Alitalo K, Yla-Herttuala S: Intravascular adenovirus-mediated VEGF-C gene transfer reduces neointima formation in balloon-denuded rabbit aorta. Circulation102:2262-2268, 2000
52. Nugent HM, Groothuis A, Seifert P, Guerraro JL, Nedelman M, Mohanakumar T, Edelman ER: Perivascular endothelial implants inhibit intimal hyperplasia in a model of arteriovenous fistulae: a safety and efficacy study in the pig. J Vasc Res39:524-533, 2002
53. Nugent HM, Sjin RT, White D, Milton LG, Manson RJ, Lawson JH, Edelman ER: Adventitial endothelial implants reduce matrix metalloproteinase-2 expression and increase luminal diameter in porcine arteriovenous grafts. J Vasc Surg46:548-556, 2007
54. Lawson JHGM, Schuman E, et al.: Safety of Vascugel Treatment After the Creation of Arteriovenous. Poster Presentation at American Society of Nephrology Renal Week, 2008
55. Luo Z, Akita GY, Date T, Treleaven C, Vincent KA, Woodcock D, Cheng SH, Gregory RJ, Jiang C: Adenovirus-mediated expression of beta-adrenergic receptor kinase C-terminus reduces intimal hyperplasia and luminal stenosis of arteriovenous polytetrafluoroethylene grafts in pigs. Circulation111:1679-1684, 2005
56. Burke SKLA, Mendenhall HV: Local application of recombinant human type i pancreatic elastase (PRT-201) to an arteriovenous fistula (AVF) increases AVF blood flow in a rabbit model. Poster Presentation at American Society of Nephrology Renal Week, 2008
57. Christi P: Autologous adipose tissue in an animal model of arterio-venous grafts. ASN Scientific Meetings, 2011